文献速递头颈与中枢神经肿瘤消化系统肿瘤乳腺癌

Oncokompas电子健康应用在癌症幸存者自我管理中的作用:一项随机对照试验

Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial.
PubMed 文献 · Lancet Oncol · 2019-12-11

本研究为在荷兰14家医院开展的随机对照试验,纳入625例头颈癌、结直肠癌、乳腺癌或淋巴瘤幸存者,评估Oncokompas(基于网络的电子健康应用)对患者自我管理激活度的效果。结论:Oncokompas未能改善癌症幸存者自我管理的知识、技能和信心。

要点

  • Oncokompas未能显著改善癌症幸存者的患者激活度。
  • 研究纳入625例幸存者,随机分为干预组和对照组。
  • 主要终点为患者激活度,6个月随访时组间差异无统计学意义。

核心结论

  • Oncokompas未能改善癌症幸存者自我管理的知识、技能和信心。

研究设计与样本

  • 非盲随机对照试验,在荷兰14家医院招募625例成年癌症幸存者,按1:1随机分为干预组(320例)和对照组(305例),按肿瘤类型分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Knowledge about the efficacy of behavioural intervention technologies that can be used by cancer survivors independently from a health-care provider is scarce. We aimed to assess the efficacy, reach, and usage of Oncokompas, a web-based eHealth application that supports survivors in self-management by monitoring health-related quality of life (HRQOL) and cancer-generic and tumour-specific symptoms and obtaining tailored feedback with a personalised overview of supportive care options. METHODS: In this non-blinded, randomised, controlled trial, we recruited patients treated at 14 hospitals in the Netherlands for head and neck cancer, colorectal cancer, breast cancer, Hodgkin lymphoma, or non-Hodgkin lymphoma. Adult survivors (aged ≥18 years) were recruited through the Netherlands Cancer Registry (NCR) and invited by their treating physician through the Patient Reported Outcomes Following Initial Treatment and Long term Evaluation of Survivorship (PROFILES) registry. Participants were randomly assigned (1:1) by an independent researcher to the intervention group (access to Oncokompas) or control group (access to Oncokompas after 6 months), by use of block randomisation (block length of 68), stratified by tumour type. The primary outcome was patient activation (knowledge, skills, and confidence for self-management), assessed at baseline, post-intervention, and 3-month and 6-month follow-up. Linear mixed models (intention-to-treat) were used to assess group differences over time from baseline to 6-month follow-up. The trial is registered in the Netherlands Trial Register, NTR5774 and is completed. FINDINGS: Between Oct 12, 2016, and May 24, 2018, 625 (21%) of 2953 survivors assessed for eligibility were recruited and randomly assigned to the intervention (320) or control group (305). Median follow-up was 6 months (IQR 6-6). Patient activation was not significantly different between intervention and control group over time (difference at 6-month follow-up 1·7 [95% CI -0·8-4·1], p=0·41). INTERPRETATION: Oncokompas did not improve the amount of knowledge, skills, and confidence for self-management in cancer survivors. This study contributes to the evidence for the development of tailored strategies for development and implementation of behavioural intervention technologies among cancer survivors. FUNDING: Dutch Cancer Society (KWF Kankerbestrijding).

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. van der Hout A, van Uden-Kraan CF, Holtmaat K, et al. Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial. Lancet Oncol. 2019. PMID: 31838009. doi:10.1016/S1470-2045(19)30675-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。